Benitec Biopharma Inc.
BNTC | NASDAQ
$10.88
-$0.14 (-1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$10.88
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:10 PM ET
Fiscal Quarter Period Ending | Q4 2026 Jun 29, 2026 | Q3 2026 Mar 30, 2026 | Q2 2026 Dec 30, 2025 | Q1 2026 Sep 29, 2025 | Q4 2025 Jun 29, 2025 | Q3 2025 Mar 30, 2025 | Q2 2025 Dec 30, 2024 | Q1 2025 Sep 29, 2024 | Q4 2024 Jun 29, 2024 | Q3 2024 Mar 30, 2024 | Q2 2024 Dec 30, 2023 | Q1 2024 Sep 29, 2023 | Q4 2023 Jun 29, 2023 | Q3 2023 Mar 30, 2023 | Q2 2023 Dec 30, 2022 | Q1 2023 Sep 29, 2022 | Q4 2022 Jun 29, 2022 | Q3 2022 Mar 30, 2022 | Q2 2022 Dec 30, 2021 | Q1 2022 Sep 29, 2021 | Q4 2021 Jun 29, 2021 | Q3 2021 Mar 30, 2021 | Q2 2021 Dec 30, 2020 | Q1 2021 Sep 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -12.81M | -11.94M | -11.84M | -8.97M | -8.81M | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M | -6.8M | -5.95M | -4.66M | -4.4M | -5.41M | -5.09M | -5.07M | -3.27M | -4.82M | -5.05M | -4M | -3.91M | -3.25M | -2.72M |
Depreciation & Amortization | 124K | 119K | 120K | 118K | 118K | 106K | 81K | 91K | 91K | 90K | 80K | 82K | 84K | 93K | 41K | 102K | 63K | 114K | 113K | 102K | 102K | 115K | 115K | 92K |
Stock-Based Compensation | 6.26M | n/a | 7.38M | 5.18M | n/a | 2.6M | 943K | 435K | 454K | 192K | n/a | 91K | n/a | 71K | n/a | 302K | n/a | 192K | 239K | 271K | 279K | 235K | 82K | n/a |
Other Working Capital | -101.2K | -530.6K | -262.02K | 160.83K | -367.03K | 659K | -606K | 43K | -661.83K | 142.52K | 115.6K | 638K | -415.2K | 200K | 56.97K | 147K | -544.53K | -459K | 1.1M | 412K | -1.52M | 1.57M | -270K | 320K |
Other Non-Cash Items | 1.44M | 7.11M | 701.01K | 125.21K | 5.66M | 2.91M | -764K | n/a | -5.8K | -78.2K | 133.31K | 1.2M | 393.12K | 4K | 210.46K | -3K | 311.12K | 5K | 23K | -18K | -19K | 4K | -1K | 38K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 51.78K | -203.06K | -139.01K | 190.79K | -5.5M | 659K | -606K | -53K | 887.8K | -2.16M | 1.25M | 1.2M | 347.58K | 200K | -492.06K | 647K | -24.23K | -459K | 1.1M | 412K | -1.52M | 1.57M | -270K | 228K |
Operating Cash Flow | -4.94M | -4.91M | -3.78M | -3.35M | -8.53M | -3.09M | -7.7M | -4.59M | -3.29M | -6.24M | -5.33M | -4.58M | -3.84M | -4.03M | -5.65M | -4.05M | -4.72M | -3.42M | -3.34M | -4.28M | -5.16M | -1.99M | -3.33M | -2.36M |
Capital Expenditures | -79K | -16.04K | -11K | n/a | -470 | -6K | -12K | n/a | -564 | -179.42K | n/a | n/a | -993 | n/a | 5.65M | n/a | -12.79K | n/a | n/a | n/a | 141K | -15K | -174K | -173K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -79K | -16.04K | -11K | n/a | -466 | -6K | -12K | n/a | -565 | -179.42K | n/a | n/a | -992 | n/a | n/a | n/a | -12.79K | n/a | n/a | n/a | 141K | -15K | -174K | -173K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -617.28K | n/a | -178.7K | n/a | n/a | 1.92M | -2K | n/a | -2.93M | n/a | n/a | -2.96M | n/a | n/a | n/a | -1.87M | n/a | n/a | n/a | n/a | -1.59M | n/a | -1.64M | n/a |
Financial Cash Flow | 241K | 4.36M | 98.23M | n/a | 4.28M | 28.41M | 17.87M | 21.66M | 40.07M | 154.89K | -49.6K | 27.92M | -264.58K | n/a | -310.01K | 16.02M | n/a | n/a | n/a | n/a | 12.67M | 3K | 9.85M | n/a |
Net Cash Flow | -4.79M | -4.03M | 94.31M | -3.27M | -5.79M | 25.3M | 10.44M | 16.98M | 36.77M | -6.23M | -5.49M | 23.39M | -4.08M | -3.99M | -6M | 12.47M | -4.55M | -3.7M | -3.4M | -4.04M | 7.78M | -2.02M | 6.56M | -2.35M |
Free Cash Flow | -5.02M | -4.93M | -3.79M | -3.35M | -8.53M | -3.09M | -7.72M | -4.59M | -3.29M | -6.42M | -5.33M | -4.58M | -3.84M | -4.03M | n/a | -4.05M | -4.73M | -3.42M | -3.34M | -4.28M | -5.02M | -2M | -3.5M | -2.53M |
Adj. Free Cash Flow | -11.28M | -4.93M | -11.17M | -8.53M | -8.53M | -5.69M | -8.66M | -5.02M | -3.75M | -6.61M | -5.33M | -4.67M | -3.84M | -4.1M | n/a | -4.35M | -4.73M | -3.61M | -3.58M | -4.55M | -5.3M | -2.24M | -3.58M | -2.53M |
Maintenance CapEx | -79K | -16.04K | -11K | n/a | n/a | -6K | -12K | n/a | -564 | -179.42K | n/a | n/a | n/a | n/a | 5.65M | n/a | -12.79K | n/a | n/a | n/a | 146.67K | -15K | -174K | -172.19K |
Growth CapEx | n/a | n/a | n/a | n/a | -470 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -993 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.67K | n/a | n/a | -810 |
Owner Earnings | -5.02M | -4.93M | -3.79M | -3.35M | -8.53M | -3.09M | -7.72M | -4.59M | -3.29M | -6.42M | -5.33M | -4.58M | -3.84M | -4.03M | n/a | -4.05M | -4.73M | -3.42M | -3.34M | -4.28M | -5.01M | -2M | -3.5M | -2.53M |
Add to Watchlist
Select watchlists to add or remove BNTC